One of the names I’ve been tracking this week is JPM.
After the recent pullback into ~$296, price swept short-term sell-side liquidity without reaching the deeper $290 pocket. Since then, we’ve seen stabilization above $300 and volume starting to rotate back in.
This doesn’t look like panic selling.
It looks more like positioning.
At the moment, price is working inside a decision area between roughly $300–314. There’s still an imbalance overhead near $314 that hasn’t been fully repaired. If we continue seeing steady bid flow and acceptance above $300, the next logical magnet becomes the upper liquidity pool around $323–324.
On the downside, I’d only get cautious if we lose $297 with acceptance. Until then, structure is still intact.
For those who trade options, one conservative idea could be a bull put spread around the 285 / 280 strikes (short-term expiry). If JPM holds structure and doesn’t revisit lower liquidity, this type of spread can offer roughly ~10-15% return on risk over a 2–3 week window depending on fills and IV.
The simpler approach is buying shares around current levels and targeting a controlled 5–6% move toward the $320s if liquidity above gets taken.
This isn’t about indicators for me.
It’s about:
• Liquidity sweep completed
• Structure holding above $300
• Imbalance overhead
• Quiet institutional rotation
For now, I’m tracking and waiting for continued confirmation through volume and acceptance.
As always, these are personal trading notes, not a recommendation.
Do your own analysis and manage risk properly.
If you have any questions, feedback, or want to understand my approach in more depth, feel free to reach out or drop a comment. I answer every question for free, your feedback helps me improve, and we both learn along the way. Likes, and comments are super appreciated too! :)
#777BlessTrading
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.